Pfizer Quietly Offers Warranty on NSCLC Drug Xalkori Should it Fail to Show Benefit

Pfizer has quietly launched what it’s calling the Pfizer Pledge, a pilot program that attaches an insurance-backed warranty to the performance of the company’s 10-year-old lung cancer drug Xalkori, promising money back.
Source: Drug Industry Daily